Eli Lilly has doubled down on its partnership with CDMO Resilience as the companies plan to invest $750 million to increase production of Lilly’s KwikPen injectable device for its diabetes and obesity medicines Mounjaro and Zepbound.
Lilly, Resilience commit $750M to boost US diabetes, obesity med production
Latest from Blog
ACG Capsules and Vantage Nutrition to exhibit at the NBJ Summit 2026
Driving the future of nutrition innovation Post Views: 0
Doctor Dr Karan Shares His Simple Formula for Eating 30g of Fibre a Day
It’s cheap and effective Post Views: 0
New Clinical Research Presented at NUTRITION 2026 Shows Superbrewed Food’s Postbiotic Cultured Protein Matches Whey in Muscle-Building Response
Novel stable isotope study conducted at Texas A&M University found Postbiotic Cultured Protein’s anabolic response and amino acid bioavailability were… Post Views: 0
Most store-bought chicken stock isn’t stock at all! Stock vs broth: Chefs explain the difference and what it means for cooking and nutrition
Picture this: you’ve just been promoted, and it calls for a celebration. You’ve already decided what it’ll look like: lunch at your place, family gathered around the table, and your nonna’s special
Ebola outbreak nears milestone, but vaccine is close
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Earlier this week, STAT’s Anil Oza went to our regular sandwich place